Medytox Solutions (MMMS) 3.0000 $MMMS Medytox Solutions,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medytox Solutions (MMMS) 3.0000 $MMMS

Medytox Solutions, Inc. Stockholders Approve Merger With CollabRx, Inc.
Marketwired - Wed Oct 28, 4:38PM CDT
Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" announced today it held its Special Meeting of Stockholders to approve the following proposals: (i) to approve and adopt the Agreement and Plan of Merger, dated as of April 15, 2015, by and among CollabRx, Inc., CollabRx Merger Sub, Inc., a direct wholly owned subsidiary of CollabRx formed for the purpose of the merger, and Medytox (the "Merger Agreement", pursuant to which Medytox will become a wholly owned subsidiary of CollabRx (the "Merger", and the transactions contemplated by such agreement (the "Merger Proposal" and (ii) to approve any motion to adjourn the Special Meeting, or any adjournment thereof, to another time or place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve and adopt the Merger Agreement and the transactions contemplated thereby (the "Adjournment Proposal".
CLRX: 0.48 (+0.05)

CollabRx Adjourns Stockholder Special Meeting to October 30, 2015
GlobeNewswire - Wed Oct 28, 4:06PM CDT
CollabRx, Inc. ("CollabRx" (NASDAQ:CLRX) announced today that the special meeting of its stockholders scheduled for Wednesday, October 28, 2015 to consider and act on several proposals recommended by CollabRx's board and management regarding its proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS) has been adjourned to Friday, October 30, 2015 at 10:30 am Pacific Time, and will take place at CollabRx's offices located at 44 Montgomery Street, Suite 800, San Francisco, CA 94104-4811.
CLRX: 0.48 (+0.05)

CollabRx Stockholder Special Meeting to be Held October 28, 2015
GlobeNewswire - Thu Oct 22, 6:09AM CDT
As previously announced, CollabRx, Inc. ("CollabRx" (NASDAQ:CLRX) will hold a special meeting of its stockholders on Wednesday, October 28, 2015, to consider and act on several proposals recommended by CollabRx's board and management regarding its proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS).
CLRX: 0.48 (+0.05)

CollabRx Announces Special Meeting of Its Stockholders to Be Held October 28, 2015
GlobeNewswire - Thu Sep 24, 5:00PM CDT
CollabRx, Inc. ("CollabRx" (NASDAQ:CLRX) today announced that the registration statement on Form S-4 and the definitive joint proxy statement/prospectus contained therein, regarding CollabRx's proposed merger with Medytox Solutions, Inc. ("Medytox" (OTCQB:MMMS), has been declared effective by the Securities and Exchange Commission (the "SEC".
CLRX: 0.48 (+0.05)

Medytox Solutions, Inc. Announces New Board Members
Marketwired - Thu Aug 13, 10:00AM CDT
Medytox Solutions, Inc. announces the election of two new board members who boast years of professional leadership in corporate governance, financial services, company restructuring, and healthcare. Michael L. Goldberg, managing director of Monarch Capital, LLC, and Robert Lee, managing partner of Sheffield Investment Partners, joined returning board members Christopher E. Diamantis, chairman and CEO of Integrated Financial Settlements, Inc.; Benjamin Frank, a retired lawyer and businessman with experience in healthcare, foreign trade, retail, business development, and government; and Seamus Lagan, CEO of Medytox Solutions, Inc. The election took place at the annual stockholders' meeting of Medytox Solutions, Inc. on August 6, 2015.

July Brings Winning Streak Of Massive Cash Jackpots To Table Mountain Casino Players Club Members
PR Newswire - Mon Jul 20, 7:13PM CDT
Reel luck and huge winnings have Table Mountain Casino Club Members getting their win on as yet another random Massive Cash Jackpot paid out again--the third one in a string of BIG jackpots to hit.

CollabRx Announces Receipt of NASDAQ Notice of Noncompliance for Bid Price
GlobeNewswire - Fri Jun 05, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company", announced today that it received a letter from The NASDAQ Stock Market LLC ("Nasdaq" stating that the bid price of the Company's common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2).
CLRX: 0.48 (+0.05)

Table Mountain Casino's Massive Cash Jackpot Pays Yet Another Lucky Winner
PR Newswire - Mon Jun 01, 6:32PM CDT
Table Mountain Casino's Lucky Club member, Gurdial of Fresno, visited his favorite casino, Table Mountain, and left with a mountain of money! The popular Massive Cash jackpot randomly paid out on the machine he was playing, showering him with $100,604.82 in cold hard cash!

CollabRx Receives Notice From Nasdaq on Change of Control
GlobeNewswire - Wed Apr 29, 6:01AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" or "the Company", today announced that it had received notice from The NASDAQ Stock Market LLC ("Nasdaq" that the Company's proposed transaction with Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox" when completed would constitute a business combination that results in a "change of control" as that term is defined in Nasdaq Listing Rule 5110(a). Accordingly, the post-transaction entity would be required to successfully complete the Nasdaq listing application process and satisfy all criteria for initial listing on Nasdaq.
CLRX: 0.48 (+0.05)

CollabRx and Medytox Solutions Sign Definitive Merger Agreement
GlobeNewswire - Thu Apr 16, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions.
CLRX: 0.48 (+0.05)

Medytox Solutions Signs Definitive Merger Agreement With CollabRx
GlobeNewswire - Thu Apr 16, 6:00AM CDT
Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox" and CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions.
CLRX: 0.48 (+0.05)

Integrated Healthcare Company, Medytox Solutions, Inc., Names New COO
Marketwired - Wed Feb 18, 10:00AM CST
Medytox Solutions, Inc. (OTCBB: MMMS), which owns and operates clinical laboratories and healthcare technology companies, announced today that it named Samuel R. Mitchell, Jr., chief operating officer. As COO, Mr. Mitchell will work to streamline performance throughout the Medytox family of companies headquartered in West Palm Beach. He will also oversee quarterly and annual financial goal management.

CollabRx announces non-binding letter of intent for proposed business combination with Medytox Solutions
M2 - Fri Jan 23, 8:03PM CST
Medical information company CollabRx (NasdaqCM:CLRX) reported on Thursday the execution of a non-binding letter of intent to negotiate a potential business combination with Medytox Solutions (OTCBB:MMMS).
CLRX: 0.48 (+0.05)

CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination
Marketwired - Thu Jan 22, 5:30AM CST
CollabRx, Inc. (NASDAQ: CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" have entered into a non-binding letter of intent to negotiate a potential business combination. Also, CollabRx and Medytox announced that they have entered into agreements that would secure funding needed by CollabRx to continue to operate while the parties negotiate a potential business combination. The potential business combination is subject to, among other things, due diligence, the execution of a definitive agreement, necessary Board of Directors and stockholder approvals and other customary conditions.
CLRX: 0.48 (+0.05)

Medytox Diagnostics' International Technologies awarded the New York State Department's Health Clinical Laboratory permit
M2 - Thu Jan 08, 4:53AM CST
Medytox Diagnostics stated on Wednesday that its New Jersey-based laboratory, International Technologies, has been certified with a Clinical Laboratory Permit by the New York State Department of Health.

Medytox Diagnostics Awarded License to Begin Lab Testing in New York State
Marketwired - Wed Jan 07, 10:06AM CST
The New York State Department of Health awarded Medytox Diagnostics, Inc.'s New Jersey-based laboratory, International Technologies, LLC, with a Clinical Laboratory Permit that allows the lab to begin servicing clients throughout New York State with a full continuum of laboratory services, including sophisticated drug screening. Medytox Diagnostics, a subsidiary of Medytox Solutions, Inc. (OTCBB: MMMS), has carved a niche serving the drug testing needs of substance abuse facilities and pain management practices at its New Jersey lab and its network of laboratories nationwide.

CORRECTION - Medytox Billing Subsidiary Expands Patient Relations Department
Marketwired - Tue Dec 30, 9:00AM CST
In the news release, "Medytox Billing Subsidiary Expands Patient Relations Department," issued Wednesday, December 24, 2014 by Medytox Solutions, Inc. (OTCBB: MMMS), we are advised by the company that the fourth paragraph should read "William DePond, M.D., COO of Medytox Diagnostics, Inc., and CEO of Medytox-owned laboratories" rather than "William DePond, M.D., COO of Medytox Solutions, Inc., and CEO of Medytox laboratories" as originally issued. Complete corrected text follows.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 21

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 16

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 7

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 17

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 23

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 20

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 13

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 14

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 20

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading

Top 5 Most Recently Viewed Articles

Axcelis Reports Q1 2025 Results: Insights and Outlook

Updated Category News Views 241

Axcelis Technologies Prepares for First Quarter 2025 Earnings Call Axcelis Technologies, Inc. (Nasdaq: ACLS), a leader in ion implantation solutions for the semiconductor sector, is set to unveil its financial results for the first quarter of 2025. The results will be announced prior to the market opening on May 6, 2025. Investors are eager to learn how the company has...

Continue Reading
Walme's $WLM Token Sale: A New Era in Web3 Finance

Updated Category News Views 490

Walme Launches $WLM Token Sale for Web3 Financial Solutions Walme, renowned for its innovative Meta-Core Wallet, is revolutionizing the way individuals manage their finances across various platforms like fiat, crypto, and DAOs. The public pre-sale of its $WLM token has commenced, marking a pivotal step toward enhancing user experience in digital finance. With a robust...

Continue Reading
Display Panel Makers Strategize Amidst Rising Utilization Rates

Updated Category News Views 119

Optimizing Panel Utilization in 2025 The latest research indicates a significant increase in the fabricational utilization plans of display panel manufacturers. This trend has been noticeable since the latter part of 2024, emphasizing a more robust outlook for the upcoming quarters. By November, the reported quarterly utilization plan reached approximately 77%, followed...

Continue Reading
Digihost's Financial Restatement and Future Outlook on Growth

Updated Category News Views 126

Understanding Digihost's Financial Restatement Digihost Technology Inc. (NASDAQ / TSXV: DGHI), a pioneering entity in energy infrastructure, has recently shared significant updates regarding its financial statements. In a move aimed at transparency, the company announced that it has amended its annual report, particularly impacting the financial results for the past...

Continue Reading
Celestica Delivers Impressive Q3 Results, Showing Growth

Updated Category News Views 190

Celestica Reports Strong Q3 Earnings Celestica, Inc. (NYSE: CLS) has recently seen a significant increase in its stock price following the release of its third-quarter earnings report. Analysts were keenly watching this quarter, and the results did not disappoint, showcasing the company's solid performance and optimistic projections for the upcoming year. Strong Earnings...

Continue Reading